Programmbereich Infektionen
Zelluläre Mikrobiologie
Mission
Projekte
Drittmittel
Methoden
Publikationen
Mitarbeiter/innen
Drittmittel
- Leibniz Research Alliance INFECTIONS
InfUrb (Speaker): Spread of antimicrobial resistance, -2025 - Leibniz Research Campus EvoLung
Interaction between microbiota, host and tuberculosis,-2024 - German Center for Infection Research (DZIF) (BMBF)
TTU-TB, Neutrophil signatures in tuberculosis, -2025 - TB Sequel II (BMBF Afrika)
Post tuberculosis disease, -2025 - FLAV4AMR (JIPAMR/BMBF)
Flavodoxin inhibitors to kill resistant bacteria, -2023 - VITALITY(EDCTP)
Vitamin D for AdoLescents with HIV to reduce musculoskeletal morbidity and ImmunopaThologY, -2025 - ERA4TB (Horizon 2020; IMI)
European Regimen Accelerator for Tuberculosis, -2025 - PlasmaPlusCorona (BMBF)
Cold plasma against SARS Cov2 and biofilm forming lung pathogens, -2024 - LPI- Basic Technology 1 (BT 1)
Multi-Dimensional, multimodal, intelligent Imaging Plattforms, tuberculosis in vivo models, -2025 - Regulatory functions of oxidative/antioxidative processes during host–pathogen interactions in tuberculosis
(DFG, East Mediterranean Cooperation), -2024
Externe Kooperationspartner
- Alexander Apt, Vladimir Yeremeev, Central Institute for Tuberculosis, Moscow, Russia; Properties on susceptibility and resistance in tuberculosis
- John Baines, MPI for Evolutionary Biology, Plön: Pulmonary microbiota in infection and immunity
- Moran Benhar, Technion-Israel Institute of Technology, Haifa, Israel: Redox reactions in tuberculosis
- Lea Ann Dailey, University Vienna: Targeted nanocarrier for anti-TB drug delivery
- Claus Feldmann, KIT Karlsruhe: : Targeted nanocarrier for anti-TB drug delivery
- Ulrich Günther, University Lübeck: Metabolome of tuberculosis infected cells
- Bernhard Hube, HKI Jena: Mixed biofilms with albicans
- Paul M. Kelly, University of Lusaka, Zambia: Vitamin D in infection and immunity
- Katharina Kranzer, LSHTM, London/Harare: Vitamin D in infection and immunity
- Manfred Lutz, University of Würzburg: Myeloid derived suppressor cells in mycobacterial infections
- Esther Meyron-Holtz, Technion-Israel Institute of Technology, Haifa, Israel: Iron in tuberculosis
- Andrea Rachow, LMU Munich: Post Tuberculosis disease
- Frank Schmidt, Weill Cornell Medicine Qatar: Proteomics of host - pathogen interactions
- Albert Sickmann, ISAS, Dortmund: Proteomics of host - pathogen interactions
- Wolfgang Streit, University Hamburg: Stenotrophomonas maltophilia pathobiology
- Jayne Sutherland, LSHTM/The Gambia: Post Tuberculosis disease
- Thomas von Woedtke, INP, Greifswald: Cold plasma in anti-infection therapy